肝移植接受者中痴呆症:使用MarketScan进行的国家分析
Jessica M Ruck1, Maria A Parra1, Matthew D Price1
1Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, Maryland.
The Journal of surgical research
|January 29, 2025
概括
在肝移植 (LT) 接受者中, Delirium 索赔很少见,仅影响 1.6% 的患者. 这种报告不足突出了需要改善在LT护理中的妄想识别和报告.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 临界护理医学 临界护理医学
- 神经科学是一个神经科学.
背景情况:
- 狂妄症是肝移植 (LT) 后经常出现的并发症.
- 之前关于LT后妄想的研究主要利用单中心数据.
- 需要进行一项国家队列研究,以了解LT接受者的妄想患病率和结果.
研究的目的:
- 调查成年肝移植接受者全国队列中 Delirium 的发病率和特征.
- 为了比较肝移植接受者与 Delirium 和没有 Delirium 之间的结果.
- 评估妄想对住院时间,费用和再入院率的影响.
主要方法:
- 利用MarketScan数据库识别2015年10月至2020年12月的成年肝移植接受者.
- 雇员要求数据以识别被诊断患有 Delirium 的肝移植接受者.
- 进行了描述性的统计分析,以比较有 Delirium 和没有 Delirium 的受试者的特征和结果.
主要成果:
- 只有1.6% (32在2051) 的肝移植接受者有 Delirium 索赔.
- 狂妄症与脑病史 (21.9%与8.2%,P=0.006) 相关.
- 患有妄想症的受试者在技术护理机构的出院率较高 (37.5%对14.3%,P=0.003),住院时间中位数较长 (24对14天,P=0.03).
结论:
- 妄想声称的低率 (1.6%) 与单中心研究中更高的患病率估计 (高达47%) 相反.
- 这种报告不足可能意味着,只有最严重的妄想病例被捕获在索赔数据中.
- 改善妄的识别和报告对于准确评估肝移植接受者的结果至关重要.
相关概念视频
Esophageal Varices-II: Clinical Features and Management
884
Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
884
Therapeutic Drug Monitoring: Affecting Factors
429
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
429
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
271
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
271
Kidney Transplant I: Introduction
827
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
827
Kidney Transplant III: Nursing Management
631
Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
631
Hepatic Encephalopathy
53
DefinitionHepatic encephalopathy is a reversible neurologic syndrome that results from advanced liver dysfunction or portosystemic shunting. It leads to disturbances in cognition, behavior, and motor function due to the brain’s exposure to gut-derived toxins that the liver fails to detoxify.EtiologyThis condition develops either in the setting of acute fulminant hepatitis or progressively during chronic liver disease, such as cirrhosis and portal hypertension. Portosystemic...
53


